Results 71 to 80 of about 273,177 (229)

Models of integration of HIV and MDR-TB care.

, 2022
Models of integration of HIV and MDR-TB care. Panel A: Fourteen clinics with full integration of DST and MDR-TB treatment on-site; Panel B: Partial integration of eight clinics with DST on-site and MDR-TB treatment off-site and one clinic with the ...
Nishi Suryavanshi (375258), Marie Ballif (368655), Stephany N. Duda (8886566), Olivier Marcy (532512), Samyra R. Cox (9182821), Matthias Egger (24558), Gary Reubenson (805627), Leslie A. Enane (5076689), Lukas Fenner (149822), Larissa Otero (308500), Jeffrey A. Tornheim (12174311), Worarat Imsanguan (12174308), Kathrin Zürcher (1807825), Marcel Yotebieng (349839)   +13 more
core   +1 more source

Patterns of Drug Resistance, Drug Resistance Conferring Mutations and Genomic DNA Methylation Revealed in Mycobacterium tuberculosis From South Africa

Tropical Medicine &International Health, EarlyView.
ABSTRACT Tuberculosis remains a major public health threat globally, with drug‐resistant strains undermining treatment efficacy. We analyzed 126 Mycobacterium tuberculosis (M. tuberculosis) isolates with diverse drug resistance spectra and selected 35 for whole genome sequencing (WGS) using Illumina NextSeq, SMRT PacBio Onso and SMRT PacBio Revio ...
Unarine Matodzi, Awelani Mutshembele, Eric Mensah, Dillon Muzondiwa, Ndivhuho A. Makhado, Oleg N. Reva   +5 more
wiley   +1 more source

MDR-TB-related costs incurred during treatment.

BackgroundWe compared the cost-consequence of a home-based multidrug-resistant tuberculosis (MDR-TB) model of care, based on task-shifting of directly observed therapy (DOT) and MDR-TB injection administration to lay health workers, to a routine clinic ...
J. Christo Heunis (13046945), N. Gladys Kigozi (13046948), Ernest Peresu (13046942), Diana De Graeve (11642908)   +3 more
core   +1 more source

MDR-TB diagnosis and treatment under GFPMDT project in China during October 2006 to December 2013.

, 2019
GFPMDT-Global Fund Programmatic Management of drug resistant tuberculosis;MDR-TB: Multi drug-resistant tuberculosis.
Hemant Deepak Shewade (760494), Kathiresan Jeyashree (4096504), Renzhong Li (538735), Lixia Wang (331745), Yunzhou Ruan (4096507), Caihong Xu (1780648), Canyou Zhang (4096510), Hui Zhang (7197)   +7 more
core   +1 more source

Evaluasi Penggunaan Algoritma TB-MDR Sebagai Alat Diagnosis TB - MDR Pada Penderita TB

Jurnal Penelitian Keperawatan Kontemporer
Latar Belakang: Kuman yang menyebabkan tuberkulosis dapat menjadi resisten terhadap obat antituberkulosis (OAT) yang digunakan untuk membunuh kuman TB. Hasil dari penelitian yang dilakukan oleh Hidayathillah, 2016 yaitu indeks kejadian TB-MDR, dimana jika terdapat penderita TB maka penderita TB tersebut dapat diprediksi apakah mempunyai risiko tinggi ...
Ariska Putri Hidayathillah, Putri Pamungkas, Aan Raivi   +2 more
openaire   +1 more source

Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai [PDF]

Journal of Krishna Institute of Medical Sciences University, 2016
Background: India is a high burden country for Tuberculosis (TB). As per the World Health Organization (WHO) statistics, 24000 cases of Multi Drug Resistant (MDR) TB were diagnosed in India in 2014.
Unnati D. Desai , Jyotsna M. Joshi
doaj  

Mānuka Honey and Leaf Bioactives: A Review of Taonga Natural Products From Leptospermum scoparium

New Zealand Journal of Botany, Volume 64, Issue 4, December 2026.
This comprehensive review of mānuka examines its cultural significance, botany, distinct genetics and unique phytochemistry. It highlights mānuka honey, enriched with antibacterial methylglyoxal derived from nectar dihydroxyacetone, and details markers used to combat honey fraud.
John W. van Klink, Suzanne M. Scheele, Nigel B. Perry   +2 more
wiley   +1 more source

Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment [PDF]

, 2020
Background Tuberculosis (TB) is a major global health problem, and anti-tuberculosis drugs can impose a hazardous effect on the patient’s liver, leading to hepatotoxicity, and are a major problem in tuberculosis patients.
Semvua, Hadija H., Mgogwe, John C., Massay, Oliva S., Chilongola, Jaffu O., Nyombi, Balthazar M.   +4 more
core   +1 more source

Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis? [PDF]

PLoS ONE, 2014
Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH). Whereas many TB diagnostics detect RIF-resistance, few detect INH-monoresistance, which is common and may increase risk of acquired MDR-TB.
Claudia M Denkinger, Madhukar Pai, David W Dowdy   +2 more
doaj   +1 more source

Optimizing Tuberculosis Incidence Prediction: A Systematic Review of Hybrid Modeling Approaches and Machine Learning Techniques

Public Health Challenges, Volume 5, Issue 4, December 2026.
This systematic review and meta‐regression compared the performance of statistical, machine learning, and hybrid models in forecasting tuberculosis (TB) incidence. The study followed PRISMA 2020 guidelines and included studies published between 2010 and 2024. Hybrid models, particularly ARIMA‐LSTM, demonstrated superior forecasting accuracy compared to
Dip Bahadur Singh, Bipindra Pandey, Bibek Giri, Yashoda Dangi, Sagun Kharel, Roshan Kumar Mahato   +5 more
wiley   +1 more source